Commentary Open Access
Volume 3 | Issue 2 | DOI: https://doi.org/10.33696/AIDS.3.019
Fostemsavir in Heavily Treatment-Experienced Individuals Living with HIV-1: Insights from the Phase 3 BRIGHTE Study
Max Lataillade1,*, Peter Ackerman1, Till Schoofs2, Andrew Clark3, Michael Kozal4
- 1ViiV Healthcare, Branford, CT, USA
- 2ViiV Healthcare, Brussels, Belgium
- 3ViiV Healthcare, Brentford, UK
- 4Yale University School of Medicine, New Haven, CT, USA
Corresponding Author
Max Lataillade, max.x.lataillade@viivhealthcare.com
Received Date: March 23, 2021
Accepted Date: June 21, 2021
Lataillade M, Ackerman P, Schoofs T, Clark A, Kozal M. Fostemsavir in Heavily Treatment-Experienced Individuals Living with HIV-1: Insights from the Phase 3 BRIGHTE Study. J AIDS HIV Treat. 2021; 3(2): 31-36.
Copyright: © 2021 Lataillade M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Older Versus Younger Men Who Have Sex with Men: Awareness of and Potential Barriers to the Use of Pre-Exposure Prophylaxis (PrEP) Medication to Prevent the Transmission of HIV
Men who have sex with other men (MSM) comprise the single largest group of individuals contracting HIV in the United States, accounting for more than one-half of all new HIV diagnoses.
Commentary on Lahiri et al. Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV
Among women living with HIV (WLWH), increases in body weight and body mass index (BMI, kg/m2) have been observed after switching to the antiretroviral therapies (ART) - Integrase Inhibitors (INSTI) and/or Tenofovir Alafenamide (TAF).
Mental Health and Cognitive Care for Successful Aging with HIV
Globally, an estimated 4.2 million people above the age of 50 now have diagnosis of HIV (Human Immunodeficiency Virus) infection. Patients with HIV can now survive well into old age. Aging with HIV has been associated with medical illness however neuropsychiatric symptoms including cognitive decline and behavioral dysregulation has been directly associated with aging and having HIV.
Painful to Discuss: The Intersection of Chronic Pain, Mental Health, and Analgesic Use among People with HIV
This retrospective chart review study aims to identify patients in an HIV clinical setting in an area of high HIV prevalence in Atlanta, Georgia, USA who have chronic pain, analgesic prescriptions, and/or mental health diagnoses.
Beyond the Numbers: Weight Gain Risk Factors, Implications, and Interventions among Individuals with HIV
Advancements in antiretroviral therapy (ART) have significantly improved life expectancy, leading to an increased prevalence of older adults with HIV. This population may face challenges related to age-related comorbidities in addition to HIV and possibly antiretroviral therapy-related comorbidities. Among those, weight gain has emerged as an increasingly recognized problem raising clinical concern.